Clinical characteristics of metachronous contralateral breast cancer following diagnosis interval [PDF]
Korean Journal of Clinical Oncology, 2015 Purpose: As the population of breast cancer survivors increasing, concerns for second primary cancer has been grown. The most frequent second primary tumor after breast cancer diagnosis is contralateral breast cancer (CBC).
Chang Hwan Lee +11 more
doaj +1 more source
Second primary malignancies in patients with a neuroendocrine neoplasm in England
Endocrine Abstracts, 2022 Introduction: Patients with neuroendocrine neoplasms (NENs) may often develop other malignancies. This study aimed to identify the frequency at which these second malignancies occurred in England. Methods: Data were extracted from the National Cancer Registration and Analysis Service (NCRAS) on all patients diagnosed with a NEN at one of eight NEN site
Beth Russell +7 more
openaire +2 more sources
Metachronous carcinoma at the colostomy site after abdominoperineal resection of rectal cancer: a case report [PDF]
Annals of Coloproctology, 2023 Metachronous carcinoma at the colostomy site is very rare after abdominoperineal resection. A 53-year-old male patient underwent an abdominoperineal resection 6 years earlier for rectal cancer developed metachronous carcinoma at the site of stoma.
Young Sun Choi +4 more
doaj +1 more source
Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis
Cancer Medicine, 2021 Background Increased risk of a second primary malignancy (SPM) before or after diagnosis of anal squamous cell carcinoma (ASCC) has been reported in a previous single‐institution study.
Krupa S. Jani +10 more
doaj +1 more source
Classic Kaposi's sarcoma as a second primary neoplasm [PDF]
International Journal of Cancer, 1999 Although the incidence of classic Kaposi's sarcoma (CKS) has been investigated, its occurrence following a primary neoplasm and its association with this first neoplasm need to be determined. We analyzed a series of 124 patients with a secondary CKS (8.4% of a total of 1485 incident cases) which occurred between 1961 and 1992 in the Jewish Israeli ...
J, Iscovich +3 more
openaire +2 more sources
Comparison of characteristics in patients with both thyroid and breast cancer: Based on order of incidence [PDF]
Korean Journal of Clinical Oncology, 2017 Purpose Clinicopathologic characteristics of patients with both thyroid and breast cancer during their lifetime were analyzed to investigate the association between the two malignancies according to the order of incidence. Methods A total of 405 patients
Joo Heung Kim +10 more
doaj +1 more source
Factors influencing occurrence of metachronous gastric cancer after endoscopic resection: a systematic review and meta-analysis [PDF]
The Korean Journal of Internal Medicine, 2023 Background/Aims Metachronous gastric cancer (MGC) can occur after endoscopic resection for gastric cancer. Further studies on factors other than Helicobacter pylori infection are needed.
Younghee Choe +5 more
doaj +1 more source
Characteristics of Synchronous and Metachronous Multiple Gastric Tumors after Endoscopic Submucosal Dissection of Early Gastric Neoplasm [PDF]
Clinical Endoscopy, 2018 Background/Aims Endoscopic submucosal dissection (ESD) has been widely accepted as a method of treatment of early gastric tumor. This study aimed to identify the incidence and characteristics of multiple gastric tumors after ESD.
Hyun Jik Lee +8 more
doaj +1 more source
Clinical characteristics and prognostic analysis of multiple primary malignant neoplasms in female patients with breast cancer or genitalia malignancies [PDF]
PeerJ, 2022 Background As public awareness of health has increased and diagnostic and treatment options have improved, the survival of patients with malignant tumors has continued to extend, and the population has been aging, the number of multiple primary malignant
Li Xiao +3 more
doaj +2 more sources
Second primary malignancies in myeloproliferative neoplasms and the role of aspirin [PDF]
Leukemia, 2019 Myeloproliferative neoplasms patients are at increased risk of thrombotic incidents and are commonly given low-dose aspirin based on mostly retrospective and extrapolated data. In this letter to the editor we have discussed potential role of aspirirn as a oncogenic or protective drug in patients with myeloproliferative neoplasms.
Marko Lucijanic +2 more
openaire +2 more sources